Published in J Neurol on August 04, 2011
Myelin water imaging reflects clinical variability in multiple sclerosis. Neuroimage (2011) 1.24
Neuroimaging biomarkers of neurodegenerative diseases and dementia. Semin Neurol (2013) 0.92
Multiple sclerosis imaging: recent advances. J Neurol (2012) 0.85
Diffusion fMRI detects white-matter dysfunction in mice with acute optic neuritis. Neurobiol Dis (2014) 0.75
Phase-Sensitive Inversion-Recovery MRI Improves Longitudinal Cortical Lesion Detection in Progressive MS. PLoS One (2016) 0.75
MR diffusion tensor spectroscopy and imaging. Biophys J (1994) 22.78
MR imaging of intravoxel incoherent motions: application to diffusion and perfusion in neurologic disorders. Radiology (1986) 11.58
Toward a quantitative assessment of diffusion anisotropy. Magn Reson Med (1996) 10.50
Functional brain mapping by blood oxygenation level-dependent contrast magnetic resonance imaging. A comparison of signal characteristics with a biophysical model. Biophys J (1993) 6.52
Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain (2005) 5.29
Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability. Ann Neurol (1999) 2.61
Diffusion tensor magnetic resonance imaging in multiple sclerosis. Neurology (2001) 2.24
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Default-mode network dysfunction and cognitive impairment in progressive MS. Neurology (2010) 2.03
The natural history of multiple sclerosis: a geographically based study. 5. The clinical features and natural history of primary progressive multiple sclerosis. Brain (1999) 1.91
Spinal cord MRI using multi-array coils and fast spin echo. II. Findings in multiple sclerosis. Neurology (1993) 1.87
Demyelination versus remyelination in progressive multiple sclerosis. Brain (2010) 1.82
Primary-progressive multiple sclerosis. Lancet Neurol (2007) 1.81
Imaging distribution and frequency of cortical lesions in patients with multiple sclerosis. Neurology (2010) 1.72
Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol (2002) 1.68
Diagnostic criteria for primary progressive multiple sclerosis: a position paper. Ann Neurol (2000) 1.66
High field MRI correlates of myelin content and axonal density in multiple sclerosis--a post-mortem study of the spinal cord. J Neurol (2003) 1.59
Investigation of MS normal-appearing brain using diffusion tensor MRI with clinical correlations. Neurology (2001) 1.58
Remyelinated lesions in multiple sclerosis: magnetic resonance image appearance. Arch Neurol (2003) 1.55
Diffusion MRI in multiple sclerosis. Neurology (2005) 1.49
In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study. Brain (2007) 1.48
MR spectroscopic evidence for glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med (2005) 1.42
Correlation of magnetization transfer ratio with clinical disability in multiple sclerosis. Ann Neurol (1994) 1.35
Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study. Neurology (2009) 1.35
Pathological study of spinal cord atrophy in multiple sclerosis suggests limited role of local lesions. Brain (2004) 1.23
Exploring the relationship between white matter and gray matter damage in early primary progressive multiple sclerosis: an in vivo study with TBSS and VBM. Hum Brain Mapp (2009) 1.22
In vivo assessment of the brain and cervical cord pathology of patients with primary progressive multiple sclerosis. Brain (2001) 1.17
Proton magnetic resonance spectroscopy in multiple sclerosis. Neuroimaging Clin N Am (2009) 1.17
1H magnetic resonance spectroscopy of chronic cerebral white matter lesions and normal appearing white matter in multiple sclerosis. J Neurol Neurosurg Psychiatry (1997) 1.16
Mean diffusivity and fractional anisotropy histograms of patients with multiple sclerosis. AJNR Am J Neuroradiol (2001) 1.16
Spinal-cord MRI in multiple sclerosis. Lancet Neurol (2003) 1.15
Metabolite changes in normal-appearing gray and white matter are linked with disability in early primary progressive multiple sclerosis. Arch Neurol (2005) 1.08
Magnetisation transfer ratio and mean diffusivity of normal appearing white and grey matter from patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (2001) 1.07
Regional gray matter atrophy in early primary progressive multiple sclerosis: a voxel-based morphometry study. Arch Neurol (2006) 1.07
Comparison of MS clinical phenotypes using conventional and magnetization transfer MRI. Neurology (1999) 1.06
Grey and white matter volume changes in early primary progressive multiple sclerosis: a longitudinal study. Brain (2005) 1.02
Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years. Brain (2006) 1.02
Localized grey matter damage in early primary progressive multiple sclerosis contributes to disability. Neuroimage (2007) 1.01
Progressive multiple sclerosis. Semin Immunopathol (2009) 1.00
A magnetization transfer histogram study of normal-appearing brain tissue in MS. Neurology (2000) 0.99
Quantification of cervical cord pathology in primary progressive MS using diffusion tensor MRI. Neurology (2005) 0.98
1H MRSI comparison of white matter and lesions in primary progressive and relapsing-remitting MS. Mult Scler (2000) 0.96
Magnetization transfer ratio in gray matter: a potential surrogate marker for progression in early primary progressive multiple sclerosis. Arch Neurol (2008) 0.96
Cognitive impairment in multiple sclerosis is associated to different patterns of gray matter atrophy according to clinical phenotype. Hum Brain Mapp (2010) 0.96
Assessment of normal-appearing white and gray matter in patients with primary progressive multiple sclerosis: a diffusion-tensor magnetic resonance imaging study. Arch Neurol (2002) 0.96
Is inflammation important in early PPMS? a longitudinal MRI study. J Neurol Neurosurg Psychiatry (2005) 0.95
Multicentre proton magnetic resonance spectroscopy imaging of primary progressive multiple sclerosis. Mult Scler (2004) 0.95
T2 lesion location really matters: a 10 year follow-up study in primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2010) 0.94
The normal appearing grey matter in primary progressive multiple sclerosis: a magnetisation transfer imaging study. J Neurol (2003) 0.93
Abnormalities in normal appearing tissues in early primary progressive multiple sclerosis and their relation to disability: a tissue specific magnetisation transfer study. J Neurol Neurosurg Psychiatry (2006) 0.92
1H magnetic resonance spectroscopy of normal appearing white matter in primary progressive multiple sclerosis. J Neurol (1999) 0.92
Functional MR imaging in multiple sclerosis. Neuroimaging Clin N Am (2009) 0.91
Comparison of multiple sclerosis clinical subgroups using navigated spin echo diffusion-weighted imaging. Magn Reson Imaging (1999) 0.91
Magnetisation transfer ratio in the normal appearing white matter predicts progression of disability over 1 year in early primary progressive multiple sclerosis. J Neurol Neurosurg Psychiatry (2007) 0.91
Predicting progression in primary progressive multiple sclerosis: a 10-year multicenter study. Ann Neurol (2008) 0.91
Correlations between structural CNS damage and functional MRI changes in primary progressive MS. Neuroimage (2002) 0.91
Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. AJNR Am J Neuroradiol (1999) 0.89
Longitudinal magnetic resonance spectroscopic imaging of primary progressive multiple sclerosis patients treated with glatiramer acetate: multicenter study. Mult Scler (2007) 0.89
Short-term accrual of gray matter pathology in patients with progressive multiple sclerosis: an in vivo study using diffusion tensor MRI. Neuroimage (2004) 0.87
Axonal injury and overall tissue loss are not related in primary progressive multiple sclerosis. Arch Neurol (2005) 0.86
Structural and functional magnetic resonance imaging correlates of motor network dysfunction in primary progressive multiple sclerosis. Eur J Neurosci (2010) 0.86
A multiparametric evaluation of regional brain damage in patients with primary progressive multiple sclerosis. Hum Brain Mapp (2009) 0.85
Functional response to active and passive ankle movements with clinical correlations in patients with primary progressive multiple sclerosis. J Neurol (2006) 0.85
Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis. Arch Neurol (2008) 0.84
Evidence for widespread movement-associated functional MRI changes in patients with PPMS. Neurology (2002) 0.83
Thalamic damage predicts the evolution of primary-progressive multiple sclerosis at 5 years. AJNR Am J Neuroradiol (2011) 0.83
Complementary roles of grey matter MTR and T2 lesions in predicting progression in early PPMS. J Neurol Neurosurg Psychiatry (2010) 0.82
T2 lesions and rate of progression of disability in multiple sclerosis. Eur J Neurol (2010) 0.82
Early imaging predicts later cognitive impairment in primary progressive multiple sclerosis. Neurology (2010) 0.81
Large-scale, multicentre, quantitative MRI study of brain and cord damage in primary progressive multiple sclerosis. Mult Scler (2008) 0.81
Hippocampal atrophy in relapsing-remitting and primary progressive MS: a comparative study. Mult Scler (2010) 0.80
Magnetisation transfer of normal appearing white matter in primary progressive multiple sclerosis. Mult Scler (1999) 0.80
Intra-voxel and inter-voxel coherence in patients with multiple sclerosis assessed using diffusion tensor MRI. J Neurol (2002) 0.80
Cervical cord FMRI abnormalities differ between the progressive forms of multiple sclerosis. Hum Brain Mapp (2011) 0.79
Lesion enhancement diminishes with time in primary progressive multiple sclerosis. Mult Scler (2010) 0.79
Magnetization transfer ratio of the spinal cord in multiple sclerosis: relationship to atrophy and neurologic disability. J Neuroimaging (2000) 0.79
Primary progressive multiple sclerosis: tactile-associated functional MR activity in the cervical spinal cord. Radiology (2009) 0.78
Functional MR imaging correlates of neuropsychological impairment in primary-progressive multiple sclerosis. AJNR Am J Neuroradiol (2010) 0.77
Proton magnetic resonance spectroscopy in primary and secondary progressive multiple sclerosis. NMR Biomed (2000) 0.75
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol (2011) 25.66
Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol (2005) 24.22
Genome-wide meta-analysis identifies novel multiple sclerosis susceptibility loci. Ann Neurol (2011) 3.52
MRI criteria for multiple sclerosis in patients presenting with clinically isolated syndromes: a multicentre retrospective study. Lancet Neurol (2007) 3.47
250 microg or 500 microg interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study. Lancet Neurol (2009) 3.37
Placebo-controlled trial of oral laquinimod for multiple sclerosis. N Engl J Med (2012) 3.16
Chronic cerebrospinal venous insufficiency and multiple sclerosis. Ann Neurol (2010) 2.63
Evidence for acute neurotoxicity after chemotherapy. Ann Neurol (2010) 2.45
MRI and the diagnosis of multiple sclerosis: expanding the concept of "no better explanation". Lancet Neurol (2006) 2.44
Cortical lesions and atrophy associated with cognitive impairment in relapsing-remitting multiple sclerosis. Arch Neurol (2009) 2.20
A randomised, double blind, placebo controlled trial with vitamin D3 as an add on treatment to interferon β-1b in patients with multiple sclerosis. J Neurol Neurosurg Psychiatry (2012) 2.13
Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol (2005) 2.10
MRI in multiple sclerosis: current status and future prospects. Lancet Neurol (2008) 2.08
Magnetic resonance imaging pattern in natalizumab-associated progressive multifocal leukoencephalopathy. Ann Neurol (2012) 2.05
Cortical adaptation in patients with MS: a cross-sectional functional MRI study of disease phenotypes. Lancet Neurol (2005) 2.01
Large-scale neuronal network dysfunction in relapsing-remitting multiple sclerosis. Neurology (2012) 2.00
White matter damage in primary progressive aphasias: a diffusion tensor tractography study. Brain (2011) 1.73
Rapid semi-automatic segmentation of the spinal cord from magnetic resonance images: application in multiple sclerosis. Neuroimage (2010) 1.71
Resting state fMRI in Alzheimer's disease: beyond the default mode network. Neurobiol Aging (2011) 1.70
Quantification of brain gray matter damage in different MS phenotypes by use of diffusion tensor MR imaging. AJNR Am J Neuroradiol (2002) 1.68
Brain gray matter changes in migraine patients with T2-visible lesions: a 3-T MRI study. Stroke (2006) 1.63
Autosomal dominant frontotemporal lobar degeneration due to the C9ORF72 hexanucleotide repeat expansion: late-onset psychotic clinical presentation. Biol Psychiatry (2013) 1.58
Neutralizing antibodies to interferon beta-1b multiple sclerosis: a clinico-radiographic paradox in the BEYOND trial. Mult Scler (2011) 1.57
Location of brain lesions predicts conversion of clinically isolated syndromes to multiple sclerosis. Neurology (2012) 1.57
MRI measurements of brainstem structures in patients with Richardson's syndrome, progressive supranuclear palsy-parkinsonism, and Parkinson's disease. Mov Disord (2010) 1.52
Language networks in semantic dementia. Brain (2009) 1.50
Brain network connectivity assessed using graph theory in frontotemporal dementia. Neurology (2013) 1.50
Weighing brain activity with the balance: Angelo Mosso's original manuscripts come to light. Brain (2013) 1.50
Apolipoprotein E epsilon4 is associated with disease-specific effects on brain atrophy in Alzheimer's disease and frontotemporal dementia. Proc Natl Acad Sci U S A (2009) 1.49
Cortical lesions in multiple sclerosis. Nat Rev Neurol (2010) 1.47
A 3-year magnetic resonance imaging study of cortical lesions in relapse-onset multiple sclerosis. Ann Neurol (2010) 1.46
White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology (2010) 1.46
A reassessment of the plateauing relationship between T2 lesion load and disability in MS. Neurology (2009) 1.45
A single, early magnetic resonance imaging study in the diagnosis of multiple sclerosis. Arch Neurol (2009) 1.41
Towards a neuroimaging biomarker for amyotrophic lateral sclerosis. Lancet Neurol (2011) 1.40
Secondary progressive multiple sclerosis: current knowledge and future challenges. Lancet Neurol (2006) 1.40
Validation of diagnostic magnetic resonance imaging criteria for multiple sclerosis and response to interferon beta1a. Ann Neurol (2003) 1.39
Clinical characteristics, course and prognosis of relapsing Devic's Neuromyelitis Optica. J Neurol (2004) 1.38
A voxel-based morphometry study of grey matter loss in MS patients with different clinical phenotypes. Neuroimage (2008) 1.30
Safety and efficacy of ofatumumab in relapsing-remitting multiple sclerosis: a phase 2 study. Neurology (2014) 1.27
Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis (2010) 1.27
Brain atrophy and lesion load predict long term disability in multiple sclerosis. J Neurol Neurosurg Psychiatry (2013) 1.26
Age-related changes in conventional, magnetization transfer, and diffusion-tensor MR imaging findings: study with whole-brain tissue histogram analysis. Radiology (2003) 1.24
Multicenter case-control study on restless legs syndrome in multiple sclerosis: the REMS study. Sleep (2008) 1.22
Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp (2010) 1.22
Will Rogers phenomenon in multiple sclerosis. Ann Neurol (2008) 1.21
Multicenter stability of diffusion tensor imaging measures: a European clinical and physical phantom study. Psychiatry Res (2011) 1.21
Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann Neurol (2013) 1.18
Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management. Lancet Neurol (2005) 1.17
Magnetization transfer MRI metrics predict the accumulation of disability 8 years later in patients with multiple sclerosis. Brain (2006) 1.16
Robust automated detection of microstructural white matter degeneration in Alzheimer's disease using machine learning classification of multicenter DTI data. PLoS One (2013) 1.15
Spinal-cord MRI in multiple sclerosis. Lancet Neurol (2003) 1.15
Diffusion-weighted MR of the brain: methodology and clinical application. Radiol Med (2005) 1.14
Cognitive dysfunction in patients with mildly disabling relapsing-remitting multiple sclerosis: an exploratory study with diffusion tensor MR imaging. J Neurol Sci (2002) 1.12
Indirect evidence for early widespread gray matter involvement in relapsing-remitting multiple sclerosis. Neuroimage (2004) 1.12
Inter-sequence and inter-imaging unit variability of diffusion tensor MR imaging histogram-derived metrics of the brain in healthy volunteers. AJNR Am J Neuroradiol (2003) 1.11
Corpus callosum damage and cognitive dysfunction in benign MS. Hum Brain Mapp (2009) 1.09
Image registration and subtraction to detect active T(2) lesions in MS: an interobserver study. J Neurol (2002) 1.09
The effect of white matter lesions on cognition in the elderly--small but detectable. Nat Clin Pract Neurol (2007) 1.07
A three-year, multi-parametric MRI study in patients at presentation with CIS. J Neurol (2008) 1.07
MRI criteria for dissemination in space in patients with clinically isolated syndromes: a multicentre follow-up study. Lancet Neurol (2006) 1.07
Voxel-based analysis derived from fractional anisotropy images of white matter volume changes with aging. Neuroimage (2008) 1.07
White matter lesions in the elderly: pathophysiological hypothesis on the effect on brain plasticity and reserve. J Neurol Sci (2008) 1.06
Huntington disease: volumetric, diffusion-weighted, and magnetization transfer MR imaging of brain. Radiology (2004) 1.05
Mean diffusivity and fractional anisotropy histogram analysis of the cervical cord in MS patients. Neuroimage (2005) 1.04
Effects of early treatment with glatiramer acetate in patients with clinically isolated syndrome. Mult Scler (2012) 1.04
Regional brain atrophy evolves differently in patients with multiple sclerosis according to clinical phenotype. AJNR Am J Neuroradiol (2005) 1.04
Assessment of MRI abnormalities of the brainstem from patients with migraine and multiple sclerosis. J Neurol Sci (2006) 1.04
MRI monitoring of immunomodulation in relapse-onset multiple sclerosis trials. Nat Rev Neurol (2011) 1.03
MRI predictors of long-term evolution in amyotrophic lateral sclerosis. Eur J Neurosci (2010) 1.03
Divergent brain network connectivity in amyotrophic lateral sclerosis. Neurobiol Aging (2012) 1.03
Brain macro- and microscopic damage in patients with paediatric MS. J Neurol Neurosurg Psychiatry (2010) 1.03
Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-establishing disease prognosis and monitoring patients. Nat Rev Neurol (2015) 1.03
Thalamic damage and long-term progression of disability in multiple sclerosis. Radiology (2010) 1.02
A diffusion tensor MRI study of patients with MCI and AD with a 2-year clinical follow-up. J Neurol Neurosurg Psychiatry (2010) 1.02
Brain reserve and cognitive reserve in multiple sclerosis: what you've got and how you use it. Neurology (2013) 1.02
Microstructural changes and atrophy in brain white matter tracts with aging. Neurobiol Aging (2010) 1.01
MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging (2011) 1.01
Diffusion-tensor magnetic resonance imaging detects normal-appearing white matter damage unrelated to short-term disease activity in patients at the earliest clinical stage of multiple sclerosis. Arch Neurol (2005) 1.01
Normal-appearing white and grey matter damage in MS. A volumetric and diffusion tensor MRI study at 3.0 Tesla. J Neurol (2007) 1.01
MR spectroscopy in multiple sclerosis. J Neuroimaging (2007) 1.01
Intercenter differences in diffusion tensor MRI acquisition. J Magn Reson Imaging (2010) 1.01
Tract-specific white matter structural disruption in patients with bipolar disorder. Bipolar Disord (2011) 1.00
Voxel-wise mapping of cervical cord damage in multiple sclerosis patients with different clinical phenotypes. J Neurol Neurosurg Psychiatry (2012) 1.00
Intrahemispheric and interhemispheric structural network abnormalities in PLS and ALS. Hum Brain Mapp (2013) 1.00
Sensorimotor network rewiring in mild cognitive impairment and Alzheimer's disease. Hum Brain Mapp (2010) 1.00
Progressive gray matter damage in patients with relapsing-remitting multiple sclerosis: a longitudinal diffusion tensor magnetic resonance imaging study. Arch Neurol (2005) 0.99
Morphology and evolution of cortical lesions in multiple sclerosis. A longitudinal MRI study. Neuroimage (2008) 0.99
Postmortem magnetic resonance imaging to guide the pathologic cut: individualized, 3-dimensionally printed cutting boxes for fixed brains. J Neuropathol Exp Neurol (2014) 0.99
Inflammation in multiple sclerosis: the good, the bad, and the complex. Lancet Neurol (2002) 0.99
The cortical signature of amyotrophic lateral sclerosis. PLoS One (2012) 0.99
Inflammatory demyelination and neurodegeneration in early multiple sclerosis. J Neurol Sci (2007) 0.98
Sensitivity-encoded diffusion tensor MR imaging of the cervical cord. AJNR Am J Neuroradiol (2003) 0.98
Immunological patterns identifying disease course and evolution in multiple sclerosis patients. J Neuroimmunol (2005) 0.97
Short-term correlations between clinical and MR imaging findings in relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol (2003) 0.97